Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading KOLs at IDF Congress 2019 2019-12-12 09:00
Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics 2019-12-11 23:55
AGC Biologics Expands Plasmid DNA Offering 2019-12-11 09:06
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH" 2019-12-11 08:00
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies 2019-12-09 22:00
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours 2019-12-09 21:01
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors 2019-12-09 21:00
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody 2019-12-09 18:00
PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided 2019-12-06 20:00
Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting 2019-12-05 21:30
Announcement of collaborative research agreement with National Cancer Center on analysis of gut bacteria related to cancer 2019-12-05 15:27
Hummingbird Bioscience Raises US$19 Million in Series B Financing 2019-12-05 10:00
Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine 2019-12-04 22:01
PathogenDx Lauded by Frost & Sullivan for Its Game-changing DNA-based Multiplex Microarray Technology 2019-12-03 22:00
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia 2019-12-03 21:30
Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US 2019-12-03 17:36
Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG 2019-12-03 01:00
Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG 2019-12-03 01:00
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset 2019-12-02 18:28
1 293 294 295 296 297 441